Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of Pazopanib in Unresectable or Metastatic Chondrosarcoma
2013-004851-19Phase 2Completed
- Sponsor
- Accelerated Community Oncology Research Network
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pazopanib in chondrosarcoma, sponsored by Accelerated Community Oncology Research Network. Primary endpoint: Disease control rate at week 16. Started Mar 2015; status: completed.
02
Drugs
pazopanib
03
Conditions
chondrosarcoma
Beyond the preview
Go deeper on 2013-004851-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004851-19.